Gilead Sciences Inc. (GILD)

76.68
0.86 1.10
NASDAQ : Health Technology
Prev Close 77.54
Open 76.75
Day Low/High 76.20 / 77.53
52 Wk Low/High 60.89 / 85.97
Volume 11.04M
Avg Volume 21.89M
Exchange NASDAQ
Shares Outstanding 1.25B
Market Cap 93.30B
EPS 4.20
P/E Ratio 19.08
Div & Yield 2.72 (3.51%)

Latest News

Merck Is All In With a Threefold Approach to Covid-19

Merck Is All In With a Threefold Approach to Covid-19

I've been long Merck for a long time, since way before this pandemic became part of our lives.

Gilead Raised to Hold at SunTrust

Mr. Market Has Been Dead Right on General Electric

Mr. Market Has Been Dead Right on General Electric

GE's problem can be summarized in one sentence: The company is burning cash.

Jim Cramer: The Hope Is Real

Jim Cramer: The Hope Is Real

I get this rally -- it's based on more than a breaking branch this time, but there are still many uncertainties.

Want to Know Why I'm Not Selling Moderna?

Want to Know Why I'm Not Selling Moderna?

I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.

Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine

Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine

PFE is collaborating with German drugmaker BioNTech in the effort to find a well tolerated, effective vaccine.

Skating on Thin Ice, Apple and Amazon Earnings, the Price of Uncertainty

Skating on Thin Ice, Apple and Amazon Earnings, the Price of Uncertainty

This contraction has been dramatic and unpredictable -- and best outcomes cannot be driven solely through economic creativity.

Boeing Has My Eye

Boeing Has My Eye

This is a lower probability trade, but with the coiled price action around BA, it wouldn't take much to spring this one to life.

As Emotions Cool, Here's My Market View

As Emotions Cool, Here's My Market View

My strategy here is to focus on shorter-term trades.

A Time to Plant And a Time to Pluck Up That Which Is Planted

* Mission accomplished? Sell in May and go away!  * In scope and duration, stocks have rallied in a manner rarely seen in history * Month-to-date April has been the best month for equities since 1974 * The S&P Index has climbed by +31.4% since the M...

Has the Fed Eliminated the Risk of a Meaningful Pullback?

Has the Fed Eliminated the Risk of a Meaningful Pullback?

While the power of the Fed is unquestionable, there will be issues that liquidity simply can't fix.

Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts

Trading Volumes Rising, GDP Forecasts, Earnings and Trading Thoughts

Market leadership may be lacking on Thursday despite rising trading volumes, plus an update on Apple, Microsoft, Mastercard, Amazon and Gilead.

Bears Can't Make Sense of Powerful Upward Momentum

Bears Can't Make Sense of Powerful Upward Momentum

Simple logic suggests that we won't be able to deny the significant economic damage that is being done forever.

Jim Cramer: The Beginning of the End of Covid-19's Reign of Terror

Jim Cramer: The Beginning of the End of Covid-19's Reign of Terror

There's now a much more reasonable chance the vast opening of American business won't lead to disaster.

I Believe Tesla's Earnings Will Be the Most Fun to Watch Wednesday Night

I Believe Tesla's Earnings Will Be the Most Fun to Watch Wednesday Night

The best play post-earnings over time on Tesla has been selling bullish put spreads that expire roughly two weeks into the close TOMORROW, the first day post-earnings.

There's Nothing New in the Fed's Statement

There's Nothing New in the Fed's Statement

We already know that the Fed is going to take all necessary measures to support the economy.

We Are Riding High on Hope, Not Logic

We Are Riding High on Hope, Not Logic

If you're looking for a longer-term market-related put play, here's something to consider.

The Re-opening Rotation Trade

We're All Rooting for Gilead Sciences in This Venture

We're All Rooting for Gilead Sciences in This Venture

I'm long GILD, but the fact is that the firm is not trying to make money off of Remdesivir at this point.

I See No Way to Put Capital to Work in a Prudent Way

I See No Way to Put Capital to Work in a Prudent Way

What's troubling many underinvested market participants is that there really has been no acknowledgment by the market of economic issues.

Markets React to Gilead Statement

The S&P 500 and other U.S. equity futures have jumped after Gilead issued a statement saying it is aware of positive data emerging from a NIAID study of investigational antiviral remdesivir for the treatment of Covid-19. The NIAID is expected to pro...

The Market Refuses to Embrace Negatives as Major Earnings Reports Roll In

The Market Refuses to Embrace Negatives as Major Earnings Reports Roll In

So far, earnings season has not been the obstacle that many have feared.

Vulnerable Markets, Reopening the Economy, Trading PepsiCo: Market Recon

Vulnerable Markets, Reopening the Economy, Trading PepsiCo: Market Recon

This week the Bureau of Economic Analysis will release its very first estimate for first quarter U.S. economic growth on a quarter over quarter, annualized, and then seasonally adjusted basis.

Nothing Seems to Bother This Market Right Now, Certainly Not Earnings

Nothing Seems to Bother This Market Right Now, Certainly Not Earnings

It is hard to fully understand how the worst economic crisis we have ever seen is not creating more pressure on stocks.

Indian Generic Maker Glenmark Seeks to Make Japanese Covid-19 Drug

Indian Generic Maker Glenmark Seeks to Make Japanese Covid-19 Drug

India's drugmakers aim to manufacture generic versions of any coronavirus 'cure', even before the full findings as to how effective they are.

Saving the Service Economy, Gilead Trials and Intel's Earnings: Market Recon

Saving the Service Economy, Gilead Trials and Intel's Earnings: Market Recon

More government funding is approved to fight Covid-19 layoffs, Gilead sells off on early reports around China trials and Intel announces earnings.

This Sentiment Survey Is Not a Bunch of 'Bull'

This Sentiment Survey Is Not a Bunch of 'Bull'

I have been following this indicator for more than 20 years and have always spent a fair bit of time scoffing at it, but let's look at this one's results.

Keep Your Eyes on Earnings

Keep Your Eyes on Earnings

Overall, the indexes are muddled and clarity is lacking on the economy, but earnings should influence the next major market move.